Several intravenous and subcutaneous Ig (SCIg) preparations are available either ... [51–53] All these factors may contribute to treatment efficacy and tolerability and thus have a significant ...

The new guideline includes evidence-based recommendations for the use of subcutaneous immunoglobulin (SCIg) for maintenance treatment in CIDP. “The updated guideline should provide physicians ...

Early this year, the FDA approved hyaluronidase-facilitated subcutaneous immunoglobulin (SCIG) 10% (Hyqvia ... and ...